Getinge AB Class B

GETI B: XSTO (SWE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
?R#LOCK|$VcLOCK|?MX&h@b

Getinge Earnings: On Track for Full-Year Guidance on Consumables Growth; Shares Fairly Valued

Getinge reported second-quarter 2026 results, with 4.6% organic sales growth and adjusted EBITA margin expanding to 17.6% from 12% year over year. Full-year guidance was maintained at 3%-5% organic sales growth, adjusted for phasing out its surgical perfusion portfolio. Shares rose 9% on the day.

Sponsor Center